Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive

Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

122 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 28
Recruiting: 13
Ph III recruiting: 2
Growth YoY: —
Industry share: 32%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (16)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03883087	A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation	unknown	Phase 2	41	Ascentage Pharma Group Inc.INDUSTRY	1	Apr 3, 2023	clinicaltrials
NCT05638763	Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia	unknown	Phase 2	15	Hospital Universitario Dr. Jose E. GonzalezOTHER	1	Dec 6, 2022	clinicaltrials